Learn more about programs such as the Partnership for Prescription Assistance that helps match those in need with free or nearly free medications or the California Partnership for Access to Treatment which helps educate opinion and philanthropic leaders about health care issues affecting communities they serve. Through these programs and others, PhRMA is working to ensure access to medications, their affordability and general health care principles remain top of mind.
- Partnership for Prescription Assistance (PPA)
www.pparx.org
The Partnership for Prescription Assistance brings together America's pharmaceutical companies, doctors, other health care providers, patient advocacy organizations and community groups to help qualifying patients who lack prescription coverage get the medicines they need through the public or private program that's right for them. Many will get them free or nearly free. Its mission is to increase awareness of patient assistance programs and boost enrollment of those who are eligible. Through this site, the Partnership for Prescription Assistance offers a single point of access to more than 475 public and private patient assistance programs, including more than 180 programs offered by pharmaceutical companies. To access the Partnership for Prescription Assistance by phone, you can call toll-free, 1-888-4PPA-NOW (1-888-477-2669).
- Pharmaceutical Industry Labor Management Association (PIL-MA)
www.pil-ma.org
The Unions and Companies of the Pharmaceutical Industry Labor-Management Association recognize that a strong domestic pharmaceutical industry providing innovative, affordable medicines is vital to the American People and the Nation. The U.S. pharmaceutical industry discovers and manufactures medicines that enhance the quality of life and longevity. The U.S. industry is the global leader in scientific research, innovation and manufacturing. The U.S. industry provides hundreds of thousands of high-paying jobs and contributes over $200 billion to the gross domestic product. At the same time, the Association recognizes the need to address issues of mutual interest and concern to the industry, its workers and all Americans, including: access to medicines and affordability of medicines; funding of innovative research and future cures; and maintaining a strong U.S. industry.
- California Partnership for Access to Treatment (CPAT)
www.caaccess.org
The California Partnership for Access to Treatment (CPAT) is a diverse network of advocacy organizations, community groups, health care providers and employers, committed to ensuring a healthy and productive California. CPAT serves as a communications, education and resource network to keep its partners and the communities they serve informed about critical issues involving access to treatment in California.
- Partnership to Fight Chronic Disease
www.fightchronicdisease.org
As the CDC has said, "The United States cannot effectively address escalating health care costs without addressing the problem of chronic diseases." Any serious policy proposal that aims to improve health care in America and control rising health care expenditures must address chronic disease. That's why a broad group of patients, providers, community organizations, business and labor groups, and health policy experts has joined together to form the Partnership to Fight Chronic Disease (PFCD) -- a national coalition of more than 110 patient, provider, and community organizations, business and labor groups, and health policy experts committed to raising awareness of the number one cause of death, disability, and rising health care costs in the U.S.: rising rates of preventable and treatable chronic diseases.
- Pharmaceutical Research and Manufacturers of America (PhRMA)
www.phrma.org
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country's leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives. PhRMA companies are leading the way in the search for new cures. PhRMA members alone invested an estimated $44.5 billion in 2007 in discovering and developing new medicines. Industry-wide research and investment reached a record $58.8 billion in 2007.
Today, in the United States only about 35 percent of all health care spending goes toward treatment and care for chronic medical conditions.
Please select either one to get started.
